LAUSR

“Working together with scientists across the world, we can accelerate research in a wide range of biomedical research areas,” says Clive Wood, senior vice-president of Discovery Research at Boehringer Ingelheim. “This exciting new initiative further expands Boehringer Ingelheim’s global external innovation footprint and will help unlock the full potential of some of our most interesting compounds.” The company also launched a search tool called BI Miner that can simultaneously search the scientific literature, patent databases and clinical trial resources for therapeutic targets and drug discovery concepts. Boehringer Ingelheim is also a member of the Structural Genomics Consortium, a public–private partnership of academic groups and pharmaceutical companies that has released nearly 60 probes to the biomedical community. The Chemical Probes Portal, a free resource that reviews chemical probes, currently ranks only around 125 compounds as high-quality chemical probes. They also Boehringer Ingelheim experiments with open-access chemical probes